MAPT and Alzheimer disease: Alzheimer’s disease (AD) is characterized by the presence of two histopathological marks in the brain, senile plaques and neurofibrillary tangles (NFT), containing amyloid beta peptide 42 (Aβ42) and phospho-tau (p-tau) respectively.